Anselm Tan

Medtech Lead at ClavystBio

Speaker

Anselm Tan leads the medtech strategy and investments at ClavystBio. With experience spanning corporate venture capital and private capital investing, he previously served as Managing Director at Heritas Capital and Partner at Philips Ventures. His earlier experience at Standard Chartered covered private equity and finance, following an engineering start at Singapore’s Defence Science & Technology Agency. Anselm currently serves on panels evaluating healthcare innovation funding. He holds a bachelor’s degree in electrical and electronic engineering from Nanyang Technological University and is a Fellow Chartered and Certified Accountant.